Suppr超能文献

心力衰竭充血治疗概述。

Overview of the Treatment of Congestion in Heart Failure.

机构信息

Hospital Universitari i Politecnic La Fe, IIS La Fe, Valencia, Spain.

Centro de Investigación Biomedica en Red (CIBERCV)-Madrid, Spain.

出版信息

Curr Pharm Des. 2023;29(20):1592-1601. doi: 10.2174/1381612829666230714153404.

Abstract

Heart failure is a major problem in developed countries, leading to a high number of hospitalizations and healthcare costs. The most common symptom of heart failure is congestion, which is also the primary reason for hospitalization. Diuretics, particularly loop diuretics, are the cornerstone of the treatment of congestion. Likewise, there are other types of diuretics with different pathways of action, bioavailability profiles, adverse reactions, and effects on the cardiovascular and renal systems. Moreover, in recent years, new therapeutic alternatives have been proposed for challenging cases of diuretic resistance, such as ultrafiltration through peripheral access or peritoneal dialysis. The main objective of this article is to provide a step-guided approach to the management of congestion in patients with heart failure in order to guide the medical practice. Despite the significant amount of research published in recent years, there are no clear algorithms for managing acute heart failure. Diuretics remain the primary treatment of acute heart failure, and nephron blockade is key, but new therapies are emerging, and ongoing research is needed to develop better strategies for managing this condition.

摘要

心力衰竭是发达国家的一个主要问题,导致大量住院和医疗保健费用。心力衰竭最常见的症状是充血,这也是住院的主要原因。利尿剂,特别是袢利尿剂,是治疗充血的基石。同样,还有其他类型的利尿剂,具有不同的作用途径、生物利用度谱、不良反应以及对心血管和肾脏系统的影响。此外,近年来,针对利尿剂抵抗的挑战性病例,已经提出了一些新的治疗替代方案,例如通过外周通路或腹膜透析进行超滤。本文的主要目的是为心力衰竭患者的充血管理提供一个分步指导方法,以指导医疗实践。尽管近年来发表了大量研究,但在管理急性心力衰竭方面尚无明确的算法。利尿剂仍然是急性心力衰竭的主要治疗方法,肾单位阻断是关键,但新的治疗方法正在出现,需要进行进一步的研究,以制定更好的策略来管理这种情况。

相似文献

1
Overview of the Treatment of Congestion in Heart Failure.
Curr Pharm Des. 2023;29(20):1592-1601. doi: 10.2174/1381612829666230714153404.
2
Diuretic-resistant heart failure and the role of ultrafiltration: A proposed protocol.
Rev Port Cardiol. 2023 Sep;42(9):797-803. doi: 10.1016/j.repc.2022.05.012. Epub 2023 Mar 21.
4
A 2018 overview of diuretic resistance in heart failure.
Rev Port Cardiol (Engl Ed). 2018 Nov;37(11):935-945. doi: 10.1016/j.repc.2018.03.014. Epub 2018 Nov 20.
5
Current Approach to Decongestive Therapy in Acute Heart Failure.
Curr Heart Fail Rep. 2015 Dec;12(6):367-78. doi: 10.1007/s11897-015-0273-5.
6
Tackling Congestion in Acute Heart Failure: Is It the Primetime for "Combo Diuretic Therapy?".
Cardiorenal Med. 2023;13(1):184-188. doi: 10.1159/000529646. Epub 2023 Feb 14.
7
Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure.
Hypertension. 2020 Oct;76(4):1045-1054. doi: 10.1161/HYPERTENSIONAHA.120.15205. Epub 2020 Aug 24.
8
Decongestion: Diuretics and other therapies for hospitalized heart failure.
Indian Heart J. 2016 Apr;68 Suppl 1(Suppl 1):S61-8. doi: 10.1016/j.ihj.2015.10.386. Epub 2015 Nov 24.
9
How to use diuretics in heart failure.
Curr Treat Options Cardiovasc Med. 2009 Dec;11(6):426-32. doi: 10.1007/s11936-009-0045-1.
10

引用本文的文献

1
Pharmacological Considerations during Percutaneous Treatment of Heart Failure.
Curr Pharm Des. 2024;30(8):565-577. doi: 10.2174/0113816128284131240209113009.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验